Delivery Order SPE2D021DA002-SPE2D325F9346

Award Date 4/7/25
Potential Completion Date 4/8/25
Potential Value $4.1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $1,602.92. The contract was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to provide the TWINRIX VACCINE SYRINGE to the Department of Defense (DoD). The contract has an ultimate completion date of August 28, 2024 and is not designated as a set-aside. As a prime vendor to the DLA, DMS Pharmaceutical Group holds a larger...
This federal contract award, valued at $2,454.93, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a firm fixed-price delivery order for the supply of TWINRIX VACCINE SYRINGE, a pharmaceutical product, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,636.62, is a firm fixed-price delivery order for the TWINRIX VACCINE SYRINGE medical supply. The contract has an ultimate completion date of April 8, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $1,399.26, is for the delivery of TWINRIX VACCINE SYRINGE with a completion date of March 24, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal government, primarily...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,808.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of TWINRIX VACCINE SYRINGE and has an ultimate completion date of August 2, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the supply of the TWINRIX VACCINE SYRINGE, with a potential value of $3,129.72. The order has a completion date of May 4, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a range of brand and generic prescription and over-the-counter drug supplies to the federal...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The $9,794.82 award is for the supply of the TWINRIX VACCINE SYRINGE, a pharmaceutical product, with a completion date of November 22, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $6,546.48, is for the delivery of TWINRIX VACCINE SYRINGE, a specialized pharmaceutical product, by March 11, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
This is a federal contract award to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $4,007.30 fixed-price delivery order contract was issued by the Defense Logistics Agency (DLA) on March 13, 2024 and has an ultimate completion date of March 14, 2024. The contract is for the delivery of TWINRIX vaccine syringes to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the TWINRIX vaccine syringe, with a potential value of $1,317.26 and a completion date of January 4, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal government, particularly...
  • SPE2D021DA002
    Indefinite Delivery Contract
  • SPE2D021DA002-SPE2D325F9346
    Delivery Order

This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The $4,091.55 firm fixed-price delivery order is for the supply of TWINRIX VACCINE SYRINGE, a pharmaceutical product. The contract has an ultimate completion date of April 8, 2025.

DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. This award is not associated with a specific set-aside designation. The company also holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a wide variety of pharmaceutical products.

Generated 7/7/25, 1:22 PM